Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × capmatinib × Thoracic × Clear all

Status

Completed 9 Terminated 7 Active not recruiting 3 Withdrawn 2 Recruiting 2 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

tazemetostat 1 taletrectinib 1 rovalpituzumab tesirine 1 rociletinib 1 pegilodecakin 1 patritumab deruxtecan 1 osimertinib 1 lorlatinib 1 dabrafenib 1 ceritinib 1 capmatinib 1 brigatinib 1 alectinib 1 Suspensions 1 Powders 1 Paclitaxel 1 Nivolumab 1 BID protein, human 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741789 2026-03-16

Managed Access Programs for INC280, Capmatinib

Novartis

No longer available

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡